Search results
Results from the WOW.Com Content Network
In the first few months of extended or continuous use of combined oral contraceptives, unscheduled bleeding or spotting may occur. [82] However, the bleeding or spotting is expected to resolve after a few months of use. [82] Menstrual suppression is commonly used for convenience especially when women go on vacation. [79]
While other standards, protocols, and guidelines exist – especially outside the United States – the WPATH SOC is the most widespread protocol used by professionals working with transgender or gender-variant people. [2] [3] [4] Version 8 of the WPATH SOC, the latest version, was released online on September 15, 2022. [1] [5]
0.5–5 mg/day Various: Estrogen: SC implant: 50–200 mg every 6–24 mos Estradiol valerate: Progynova: Estrogen: Oral: 2–10 mg/day Progynova: Estrogen: Sublingual: 1–8 mg/day Delestrogen [c] Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks Estradiol cypionate: Depo-Estradiol: Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks ...
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.
It was first published in 1949, [2] as the National Formulary, with updated versions appearing every three years until 1976. The fifth version in 1957 saw its name change to The British National Formulary. [4] [5] A new-look version, under the auspices of Owen Wade, was released in 1981.
Hormone replacement therapy (HRT), also known as menopausal hormone therapy or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause. [1] [2] Effects of menopause can include symptoms such as hot flashes, accelerated skin aging, vaginal dryness, decreased muscle mass, and ...
The most common side effects of the norgestrel include irregular bleeding, headaches, dizziness, nausea, increased appetite, abdominal pain, cramps, or bloating. [2] Norgestrel is a progestin , or a synthetic progestogen , and hence is an agonist of the progesterone receptor , the biological target of progestogens like progesterone . [ 6 ]
[1] The test is performed by administering a progestogen , such as progesterone either as an intramuscular injection or oral medroxyprogesterone acetate (Provera). If the patient has sufficient serum estradiol (greater than 50 pg/mL), withdrawal bleeding should occur 2–7 days after the progestin is withdrawn, indicating that the patient's ...